+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vaccines Market - Global Forecast 2025-2030- Product Image
Vaccines Market - Global Forecast 2025-2030- Product Image
Sale

Vaccines Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4985895
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global vaccines market is advancing rapidly, shaped by ongoing innovation and new strategic partnerships across both established and emerging markets. Senior decision-makers are navigating an increasingly complex landscape as competitive differentiation becomes rooted in scientific advances, regional demand drivers, and dynamic supply chain strategies.

Market Snapshot: Vaccines Market Growth and Trends

The vaccines market grew from USD 76.05 billion in 2024 to USD 81.87 billion in 2025. It is projected to sustain momentum with a CAGR of 7.72%, reaching USD 118.85 billion by 2030. This trajectory reflects dynamic adaptation to technological shifts, strong regulatory support, and increasing investment in both preventative and therapeutic solutions. Intensified collaboration between multinational manufacturers and local stakeholders underscores competitive expansion and resilience in the face of shifting demand and regulatory landscapes.

Scope & Segmentation

Vaccine industry stakeholders benefit from an in-depth analysis of the following market segments and evolving technologies:

  • Type: Inactivated vaccines, live-attenuated vaccines, messenger RNA (mRNA) vaccines, subunit, recombinant, polysaccharide and conjugate vaccines, toxoid vaccines, viral vector vaccines.
  • Product Type: BCG, COVID-19, DPTa, hepatitis A/hepatitis B, HPV, influenza, Japanese encephalitis, measles-mumps-rubella (MMR), rotavirus.
  • Vaccine Combination: Mono-valent vaccines, multi-valent vaccines.
  • Vaccine Classification: Preventive vaccines, therapeutic vaccines.
  • Route of Administration: Intramuscular, intranasal, oral, subcutaneous.
  • Dosage: Multi-dose, single-dose.
  • Age Group: Adult, geriatric, pediatric (including infants and toddlers).
  • End User: Academic and research institutes, hospitals and clinics, vaccination centers.
  • Regions: Americas (including key US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with leading countries), Asia-Pacific (notably China, India, Japan, Australia, and Southeast Asian nations).
  • Technological Platforms: Messenger RNA, viral vector, synthetic biology, adjuvant engineering, blockchain and IoT-enabled supply chain technologies.
  • Notable Companies: Coverage extends to multinational leaders and innovative biotechs such as Abbott Laboratories, AstraZeneca PLC, BioNTech SE, Moderna, Inc., Sanofi S.A., Serum Institute of India, and others.

Key Takeaways for Decision-Makers

  • Strong public-private partnerships continue to align regulatory, financing, and manufacturing goals, impacting supply resilience and driving the evolution of vaccine standards.
  • Innovation in vaccine platforms, including mRNA and viral vector technologies, supports accelerated R&D timelines and enables flexible responses to emerging pathogens.
  • Regional manufacturing expansion and technology transfer agreements foster supply chain agility and broaden market access, especially in Asia-Pacific and other high-growth markets.
  • Segment-specific strategies covering product combinations, administration routes, and tailored dosage formats offer opportunities for targeted portfolio optimization and resource allocation.
  • Community engagement, digital supply chain systems, and regulatory harmonization efforts are furthering vaccine confidence and market penetration, highlighting the need for integrated stakeholder engagement.

Tariff Impact: Navigating U.S. Policy Changes

Recent tariff revisions in the United States are impacting the cost of raw materials, specialty chemicals, and packaging components for vaccine manufacturing. Companies are adjusting sourcing strategies and shifting toward more regionalized manufacturing to sustain competitive pricing and supply chain continuity. Enhanced customs planning and investment in logistics technology support seamless international distribution, while bilateral trade negotiations aim to reduce the burden of new tariffs on essential health commodities.

Research Methodology & Data Sources

This report uses a mixed-methods approach, combining primary interviews with industry leaders and regulatory experts, alongside a robust review of peer-reviewed journals, white papers, and industry data. Cross-validation and triangulation ensure nuanced, comprehensive, and reliable insights across the global vaccines sector.

Why This Report Matters

  • Enables confident strategic decisions by offering granular market segmentation and actionable insights tailored for executive leadership.
  • Clarifies the impact of new technologies, evolving trade regulations, and competitive shifts across global regions and product categories.
  • Supports prioritization of investments in vaccine innovation, supply chain improvements, and collaborative partnerships for long-term growth.

Conclusion

In this evolving vaccines market, actionable intelligence and stakeholder alignment are essential to navigate disruption, drive equitable access, and secure organizational resilience. This report provides senior decision-makers with the strategic clarity needed to stay ahead in a rapidly transforming industry.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of mRNA vaccine platforms for next-generation infectious disease prevention
5.2. Development of thermostable vaccine formulations for ultra-cold chain independence globally
5.3. Integration of artificial intelligence in vaccine antigen design and clinical trial optimization
5.4. Emergence of universal pan-coronavirus vaccines to address multiple SARS-related strains
5.5. Expansion of intranasal and mucosal vaccine delivery methods for improved immunity
5.6. Growth of personalized cancer vaccines harnessing neoantigen profiling and immunotherapy
5.7. Blockchain-enabled vaccine supply chain tracking enhancing transparency and trust
5.8. Collaborative public-private initiatives driving equitable vaccine access in low-income nations
5.9. Surge in global funding fueling development of thermostable vaccines for remote regions
5.10. Adoption of next-generation adjuvant formulations to boost universal influenza vaccine efficacy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vaccines Market, by Type
8.1. Introduction
8.2. Inactivated Vaccines
8.3. Live-Attenuated Vaccines
8.4. Messenger RNA Vaccines
8.5. Subunit, Recombinant, Polysaccharide, & Conjugate Vaccines
8.6. Toxoid Vaccines
8.7. Viral Vector Vaccines
9. Vaccines Market, by Product Type
9.1. Introduction
9.2. BCG
9.3. COVID-19
9.4. DPTa
9.5. Hepatitis A/Hepatitis B
9.6. HPV
9.7. Influenza
9.8. Japanese Encephalitis
9.9. Measles-Mumps-Rubella (MMR)
9.10. Rotavirus
10. Vaccines Market, by Vaccine Combination
10.1. Introduction
10.2. Mono-Valent Vaccines
10.3. Multi-Valent Vaccines
11. Vaccines Market, by Vaccine Classification
11.1. Introduction
11.2. Preventive Vaccines
11.3. Therapeutic Vaccines
12. Vaccines Market, by Route of Administration
12.1. Introduction
12.2. Intramuscular
12.3. Intranasal
12.4. Oral
12.5. Subcutaneous
13. Vaccines Market, by Dosage
13.1. Introduction
13.2. Multi Dose
13.3. Single Dose
14. Vaccines Market, by Age Group
14.1. Introduction
14.2. Adult
14.3. Geriatric
14.4. Pediatric
14.4.1. Infants
14.4.2. Toddlers
15. Vaccines Market, by End User
15.1. Introduction
15.2. Academic & Research Institutes
15.3. Hospitals & Clinics
15.4. Vaccination Centers
16. Americas Vaccines Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Vaccines Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Vaccines Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Abbott Laboratories
19.3.2. Astellas Pharma Inc.
19.3.3. AstraZeneca PLC
19.3.4. Bavarian Nordic A/S
19.3.5. Bharat Biotech Ltd.
19.3.6. Biological E. Limited
19.3.7. BioNTech SE
19.3.8. Blue Lake Biotechnology
19.3.9. Capricor Therapeutics, Inc.
19.3.10. Chongqing Zhifei Biological Products Co., Ltd.
19.3.11. CSL Limited
19.3.12. CureVac N.V.
19.3.13. Daiichi Sankyo Company, Limited.
19.3.14. Gennova Biopharmaceuticals Limited
19.3.15. GlaxoSmithKline PLC
19.3.16. Haffkine Bio-Pharmaceutical Corporation Ltd.
19.3.17. Incepta Pharmaceuticals Ltd.
19.3.18. Inovio Pharmaceuticals, Inc.
19.3.19. Johnson & Johnson Services, Inc.
19.3.20. Merck & Co., Inc.
19.3.21. Moderna, Inc.
19.3.22. Novavax, Inc.
19.3.23. Pfizer Inc.
19.3.24. Sanofi S.A.
19.3.25. Serum Institute of India Pvt. Ltd.
19.3.26. Sinovac Biotech Ltd.
19.3.27. Takeda Pharmaceutical Company Limited
19.3.28. VBI Vaccines Inc.
19.3.29. Versatope Therapeutics
19.3.30. Zydus Lifesciences Limited
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. VACCINES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VACCINES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VACCINES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL VACCINES MARKET SIZE, BY DOSAGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL VACCINES MARKET SIZE, BY DOSAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 20. GLOBAL VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 31. VACCINES MARKET: RESEARCHAI
FIGURE 32. VACCINES MARKET: RESEARCHSTATISTICS
FIGURE 33. VACCINES MARKET: RESEARCHCONTACTS
FIGURE 34. VACCINES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VACCINES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VACCINES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VACCINES MARKET SIZE, BY LIVE-ATTENUATED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VACCINES MARKET SIZE, BY LIVE-ATTENUATED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VACCINES MARKET SIZE, BY MESSENGER RNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VACCINES MARKET SIZE, BY MESSENGER RNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VACCINES MARKET SIZE, BY SUBUNIT, RECOMBINANT, POLYSACCHARIDE, & CONJUGATE VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VACCINES MARKET SIZE, BY SUBUNIT, RECOMBINANT, POLYSACCHARIDE, & CONJUGATE VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VACCINES MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VACCINES MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VACCINES MARKET SIZE, BY BCG, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VACCINES MARKET SIZE, BY BCG, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VACCINES MARKET SIZE, BY COVID-19, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VACCINES MARKET SIZE, BY COVID-19, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VACCINES MARKET SIZE, BY DPTA, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VACCINES MARKET SIZE, BY DPTA, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VACCINES MARKET SIZE, BY HEPATITIS A/HEPATITIS B, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VACCINES MARKET SIZE, BY HEPATITIS A/HEPATITIS B, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VACCINES MARKET SIZE, BY HPV, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VACCINES MARKET SIZE, BY HPV, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VACCINES MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VACCINES MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VACCINES MARKET SIZE, BY JAPANESE ENCEPHALITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VACCINES MARKET SIZE, BY JAPANESE ENCEPHALITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VACCINES MARKET SIZE, BY MEASLES-MUMPS-RUBELLA (MMR), BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VACCINES MARKET SIZE, BY MEASLES-MUMPS-RUBELLA (MMR), BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VACCINES MARKET SIZE, BY MONO-VALENT VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VACCINES MARKET SIZE, BY MONO-VALENT VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VACCINES MARKET SIZE, BY MULTI-VALENT VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VACCINES MARKET SIZE, BY MULTI-VALENT VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VACCINES MARKET SIZE, BY PREVENTIVE VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VACCINES MARKET SIZE, BY PREVENTIVE VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VACCINES MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VACCINES MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VACCINES MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VACCINES MARKET SIZE, BY INTRANASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VACCINES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VACCINES MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VACCINES MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VACCINES MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VACCINES MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VACCINES MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VACCINES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VACCINES MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL VACCINES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL VACCINES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL VACCINES MARKET SIZE, BY INFANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL VACCINES MARKET SIZE, BY INFANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL VACCINES MARKET SIZE, BY TODDLERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL VACCINES MARKET SIZE, BY TODDLERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL VACCINES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL VACCINES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL VACCINES MARKET SIZE, BY VACCINATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL VACCINES MARKET SIZE, BY VACCINATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 133. CANADA VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 141. CANADA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 144. CANADA VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 145. CANADA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 146. CANADA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 147. CANADA VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 148. CANADA VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 149. CANADA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. CANADA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. MEXICO VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 158. MEXICO VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 159. MEXICO VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 164. MEXICO VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 165. MEXICO VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 166. MEXICO VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 167. MEXICO VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. GERMANY VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 250. GERMANY VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 251. GERMANY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. GERMANY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 256. GERMANY VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 257. GERMANY VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 258. GERMANY VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 259. GERMANY VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. GERMANY VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. FRANCE VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 262. FRANCE VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 263. FRANCE VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 266. FRANCE VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 267. FRANCE VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 268. FRANCE VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 269. FRANCE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 274. FRANCE VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 275. FRANCE VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 276. FRANCE VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 277. FRANCE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. FRANCE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. ITALY VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 298. ITALY VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 299. ITALY VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. ITALY VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. ITALY VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 302. ITALY VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 303. ITALY VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 304. ITALY VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 305. ITALY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. ITALY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. ITALY VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 308. ITALY VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 309. ITALY VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. ITALY VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. ITALY VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 312. ITALY VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 313. ITALY VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. ITALY VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SPAIN VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 316. SPAIN VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 317. SPAIN VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. SPAIN VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. SPAIN VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 320. SPAIN VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 321. SPAIN VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 322. SPAIN VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 323. SPAIN VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 324. SPAIN VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 325. SPAIN VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 326. SPAIN VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 327. SPAIN VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 328. SPAIN VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 329. SPAIN VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 330. SPAIN VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 331. SPAIN VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. SPAIN VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 340. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 341. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 342. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 343. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 344. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 345. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 346. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 347. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 348. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 351. SAUDI ARABIA VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 352. SAUDI ARABIA VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 353. SAUDI ARABIA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 354. SAUDI ARABIA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 355. SAUDI ARABIA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 356. SAUDI ARABIA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 357. SAUDI ARABIA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 358. SAUDI ARABIA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 359. SAUDI ARABIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 360. SAUDI ARABIA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 361. SAUDI ARABIA VACCINES MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 362. SAUDI ARABIA VACCINES MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 363. SAUDI ARABIA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 364. SAUDI ARABIA VACCINES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 365. SAUDI ARABIA VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 366. SAUDI ARABIA VACCINES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 367. SAUDI ARABIA VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 368. SAUDI ARABIA VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 369. SOUTH AFRICA VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 370. SOUTH AFRICA VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 371. SOUTH AFRICA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 372. SOUTH AFRICA VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 373. SOUTH AFRICA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2024 (USD MILLION)
TABLE 374. SOUTH AFRICA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025-2030 (USD MILLION)
TABLE 375. SOUTH AFRICA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 376. SOUTH AFRICA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 377. SOUTH AFRICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 378. SOUTH AFRICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 379. SOUTH AFRICA VACCINES MARKET SIZE, BY DO

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bharat Biotech Ltd.
  • Biological E. Limited
  • BioNTech SE
  • Blue Lake Biotechnology
  • Capricor Therapeutics, Inc.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • CSL Limited
  • CureVac N.V.
  • Daiichi Sankyo Company, Limited.
  • Gennova Biopharmaceuticals Limited
  • GlaxoSmithKline PLC
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Incepta Pharmaceuticals Ltd.
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • VBI Vaccines Inc.
  • Versatope Therapeutics
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 81.87 Billion
Forecasted Market Value ( USD ) by 2030 $ 118.85 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Malaria Vaccine Market - Global Forecast 2025-2030 - Product Image

Malaria Vaccine Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Respiratory Disease Vaccine Market - Global Forecast 2025-2030 - Product Image

Respiratory Disease Vaccine Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report by Type (Viral, Bacterial, Combination), Infection (COVID-19, Influenza), Age Group, Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report by Type (Viral, Bacterial, Combination), Infection (COVID-19, Influenza), Age Group, Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SkyZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine), By End Use (Private Healthcare Settings), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SkyZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine), By End Use (Private Healthcare Settings), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035, by Application Area, Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions - Product Image

mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035, by Application Area, Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions

  • Report
  • 343 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.